Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

John C. Ruckdeschel, Dianne M. Finkelstein, David S. Ettinger et al. · Journal of Clinical Oncology · 1986 · 343 citations

Medicine, Oncology, Pharmacology +12

Cancer Statistics, 1989

E. Silverberg, J. A. Lubera · CA A Cancer Journal for Clinicians · 1989 · 315 citations · Full text

Public Health, Oncology, Cancer Epidemiology +12

New folate analogs of the 10-deaza-aminopterin series Basis for structural design and biochemical and pharmacologic properties

Francis M. Sirotnak, Joseph I. DeGraw, D. M. Moccio et al. · Cancer Chemotherapy and Pharmacology · 1984 · 143 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

New folate analogs of the 10-deaza-aminopterin series

Francis M. Sirotnak, Joseph I. DeGraw, Franz A. Schmid et al. · Cancer Chemotherapy and Pharmacology · 1984 · 137 citations

Pharmacy, Biochemistry, Medicinal Chemistry +9